Sonarium Medical

3D Ultrasound System for Breast Cancer Diagnosis

Health Tech & Life Sciences
Non Active, Dec 2020 ceased to operate
Follow

Company Overview

Snapshot

Founded in July 2009 by Michael Berman, Sonarium Medical operated with 1–10 employees. The company focused on developing a high-accuracy tomographic ultrasound detection system for breast cancer, but ceased operations in December 2020.

Business overview

Sonarium Medical developed a high-accuracy tomographic ultrasound detection system for breast cancer, utilizing volumetric tomography and a real-time 3D ultrasound system. This technology aimed to automatically scan the entire breast without compression, improving patient flow and increasing diagnostic accuracy. The company's imaging system was designed for early detection, featuring a transducer coupled with two-dimensional phased-array probes to provide 3D real-time diagnostics and instant procedure guidance. Sonarium Medical operated within the Health Tech & Life Sciences sector, specifically in Medical Devices and Diagnostics Devices, targeting healthcare providers with its B2B business model.

Log in to access full profile

Company Intelligence Q&A

What was Sonarium Medical's primary focus?
Sonarium Medical focused on developing a high-accuracy tomographic ultrasound detection system for breast cancer diagnosis.
When was Sonarium Medical founded?
Sonarium Medical was founded in July 2009.
Who was the founder of Sonarium Medical?
Michael Berman was the founder and CTO of Sonarium Medical.
What technology did Sonarium Medical utilize for breast cancer detection?
Sonarium Medical's system was based on volumetric tomography and a real-time 3D ultrasound system, designed to provide 3D real-time diagnostics.
What was the operational status of Sonarium Medical?
Sonarium Medical ceased to operate in December 2020.
Log in to access full profile